Research

Publications

Full list of peer-reviewed papers, reviews, and book chapters from the lab.

Year
Author
2025

Comprehensive Analysis of Extracellular Matrix Remodelling via Cyclophilin Inhibition in Human Models of Alcohol-Related Liver Fibrosis

Rastovic U, Campinoti S, Wei L, Almeida B, Bozzano SF, Amiri R, Harris N, Ajayi O, Koay TS, Kerins C, et al.

British Journal of Pharmacology · 2025

fibrosiscyclophilinALDextracellular matrix
2023

Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease

Rastovic U, Bozzano SF, Riva A, Simoni-Nieves A, Harris N, Miquel R, Lackner C, Zen Y, Zamalloa A, Menon K, et al.

International Journal of Molecular Sciences · 2023

precision-cut liver slicesALDex vivo model
2023

Patient-Derived Precision Cut Tissue Slices from Primary Liver Cancer as a Potential Platform for Preclinical Drug Testing

Jagatia R, Doornebal EJ, Rastovic U, Harris N, Feyide M, Lyons AM, Miquel R, Zen Y, Zamalloa A, Malik F, et al.

2023

liver cancerprecision-cut slicesdrug testing
2023

Giant Mitochondria in Human Liver Disease

Shami GJ, Samarska IV, Koek GH, Li A, Palma E, Chokshi S, Wisse E, Braet F

Liver International · 2023

megamitochondrialiver diseasemitochondria
2022

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment

Doornebal EJ, Harris N, Riva A, Jagatia R, Pizanias M, Prachalias A, Menon K, Preziosi M, Zamalloa A, Miquel R, et al.

Frontiers in Endocrinology · 2022

liver metastasestumour microenvironmentex vivo model
2022

Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer

Carles-Fontana R, Heaton N, Palma E, Khorsandi SE

Cancers · 2022

extracellular vesiclesmitochondriacancer
2021

Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma

Sükei T, Palma E, Urbani L

Cancers · 2021

hepatocellular carcinomatumour microenvironmentHCC
2021

Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-Bacterial Immunity

Riva A, Palma E, Devshi D, Corrigall D, Adams H, Heaton N, Menon K, Preziosi M, Zamalloa A, Miquel R, et al.

Frontiers in Physiology · 2021

TIM3ALDimmunitygalectin-9
2020

Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease

Palma E, Riva A, Moreno C, Odena G, Mudan S, Manyakin N, Miquel R, Degré D, Trepo E, Sancho-Bru P, et al.

Alcoholism: Clinical and Experimental Research · 2020

mitochondrial dynamicsALDalcoholic liver disease
2019

Dynamin-1-Like Protein Inhibition Drives Megamitochondria Formation as an Adaptive Response in Alcohol-Induced Hepatotoxicity

Palma E, Ma X, Riva A, Iansante V, Dhawan A, Wang S, Ni HM, Sesaki H, Williams R, Ding WX, et al.

American Journal of Pathology · 2019

DRP1megamitochondriahepatotoxicityALD
2019

Precision-Cut Liver Slices: A Versatile Tool to Advance Liver Research

Palma E, Doornebal EJ, Chokshi S

Hepatology International · 2019

precision-cut liver slicesliver researchex vivo
2019

Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis

Stärkel P, Schnabl B, Leclercq S, Komuta M, Bataller R, Argemi J, Palma E, Chokshi S, Hellerbrand C, Maccioni L, et al.

Hepatology Communications · 2019

IL-6ALDfibrosisinterferon
2016

Osteopontin Is a Proximal Effector of Leptin-Mediated Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Coombes JD, Choi SS, Swiderska-Syn M, Manka P, Reid DT, Palma E, Briones-Orta MA, Xie G, Younis R, Kitamura N, et al.

Biochimica et Biophysica Acta · 2016

osteopontinNASHfibrosisleptin
2015

Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients with Acute Alcoholic Hepatitis

Markwick LJL, Riva A, Ryan JM, Cooksley H, Palma E, Tranah TH, Manakkat Vijay GK, Vergis N, Thursz M, Evans A, et al.

Gastroenterology · 2015

PD1TIM3alcoholic hepatitisimmunity
2014

NIM811, a Cyclophilin Inhibitor without Immunosuppressive Activity, Is Beneficial in Collagen VI Congenital Muscular Dystrophy Models

Zulian A, Rizzo E, Schiavone M, Palma E, Tagliavini F, Blaauw B, Merlini L, Maraldi NM, Sabatelli P, Braghetta P, et al.

Human Molecular Genetics · 2014

cyclophilinmuscular dystrophycollagen VINIM811
2012

Critical Evaluation of the Use of Cell Cultures for Inclusion in Clinical Trials of Patients Affected by Collagen VI Myopathies

Sabatelli P, Palma E, Angelin A, Squarzoni S, Urciuolo A, Pellegrini C, Tiepolo T, Bonaldo P, Gualandi F, Merlini L, et al.

Journal of Cellular Physiology · 2012

collagen VImyopathycell cultureclinical trial
2011

A Glutamine Synthetase Inhibitor Increases Survival and Decreases Cytokine Response in a Mouse Model of Acute Liver Failure

Jambekar AA, Palma E, Nicolosi L, Rasola A, Petronilli V, Chiara F, Bernardi P, Needleman R, Brusilow WSA

Liver International · 2011

glutamine synthetaseacute liver failurecytokines
2009

Genetic Ablation of Cyclophilin D Rescues Mitochondrial Defects and Prevents Muscle Apoptosis in Collagen VI Myopathic Mice

Palma E, Tiepolo T, Angelin A, Sabatelli P, Maraldi NM, Basso E, Forte MA, Bernardi P, Bonaldo P

Human Molecular Genetics · 2009

cyclophilin Dmitochondriacollagen VImyopathy
2009

The Cyclophilin Inhibitor Debio 025 Normalizes Mitochondrial Function, Muscle Apoptosis and Ultrastructural Defects in Col6a1-/- Myopathic Mice

Tiepolo T, Angelin A, Palma E, Sabatelli P, Merlini L, Nicolosi L, Finetti F, Braghetta P, Vuagniaux G, Dumont JM, et al.

British Journal of Pharmacology · 2009

cyclophilin inhibitorDebio 025mitochondriamyopathy